Engineering lactate-modulating nanomedicines for cancer therapy
J Chen, Y Zhu, C Wu, J Shi - Chemical Society Reviews, 2023 - pubs.rsc.org
Lactate in tumors has long been considered “metabolic junk” derived from the glycolysis of
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …
Engineering lactate-modulating nanomedicines for cancer therapy
J Chen, Y Zhu, C Wu, J Shi - Chemical Society reviews, 2023 - pubmed.ncbi.nlm.nih.gov
Lactate in tumors has long been considered" metabolic junk" derived from the glycolysis of
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …
Engineering lactate-modulating nanomedicines for cancer therapy.
J Chen, Y Zhu, C Wu, J Shi - Chemical Society Reviews, 2023 - europepmc.org
Lactate in tumors has long been considered" metabolic junk" derived from the glycolysis of
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …